Marrow protection - transduction of hematopoietic cells with drug resistance genes

References

• Weiss RB. Introduction: dose-intensive therapy for adult malignancies. Semin Oncol 1999;26:1–5.
   Google Scholar
• Moritz T, Williams DA. Transfer of drug-resistance genes tohematopoietic precursors. In: Bertino JR, editor. Encyclopedia of cancer. Vol. 3. San Diego: Academic Press, 1997: 1765–76.
   Google Scholar
• Maze R, Hanenberg H, Williams D. Establishing chemo-resistance in hematopoietic progenitor cells. Mol Med Today 1997;3:350–8.
   Google Scholar
• Koc ON, Allay JA, Lee K et al. Transfer of drug resistancegenes into hematopoietic progenitors to improve chemotherapy tolerance. Semin Oncol 1996;23:46–65.
   PubMed Web of Science ®Google Scholar
• Davis BM, Koc ON, Reese JS, Gerson SL. 06-benzylgua-nine-resistant mutant MGMT genes improve hematopoietic cell tolerance to alkylating agents. In: Benin° JR, editor. Marrow protection. Basel. Karger, ProgExp Tumor Res 1999;H;36: 65–81.
   Google Scholar
• Becker S, Wasser S, Hauses M et al. Correction of respira- tory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. Hum Gene Ther 1998;9:1561–70.
   PubMed Web of Science ®Google Scholar
• Correll PH, Colilla S, Dave HP, Karlsson S. High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells. Blood 1992;80:331–6.
   PubMed Web of Science ®Google Scholar
• Dirksen U, Nishinakamura R, Groneck P et al. Human pul-monary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expres-sion. 3 Clin Invest 1997;100: 2211–17.
   Google Scholar
• Kume A, Dinauer MC. Gene therapy for chronic granulo-matous disease. Lab Clin Med 2000;135:122–8.
   Google Scholar
• Joyner A, Keller G, Phillips RA, Bernstein A. Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells. Nature 1983;305:556–8.
   PubMed Web of Science ®Google Scholar
• Williams DA, Lemischka IR, Nathan DG, Mulligan RC. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 1984;310:476–80.
   PubMed Web of Science ®Google Scholar
• Keller G, Paige C, Gilboa E, Wagner EF Expression of a for-eign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature 1985;318: 149–54.
   PubMed Web of Science ®Google Scholar
• Dick JE, Magli MC, Huszar D et al. Introduction of a select-able gene in primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Ce/11985;42:71–9.
   PubMed Web of Science ®Google Scholar
• Brenner MK, Rill DR, Holladay MS et al Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 1993;342:1139–7.
   Google Scholar
• Brenner MK, Rill DR, Moen RC et al. Gene marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993;341:85–6.
   PubMed Web of Science ®Google Scholar
• Baum C, Hegewisch-Becker S, Eckert HG et al. Novel retro-viral vectors for efficient expression of the multidrug resistance (MDR-1) gene in early hematopoietic cells. Virol 1995;69:7541–7.
   Google Scholar
• Hawley RG, Lieu FH, Fong AZ, Hawley TS. Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1994;1:136–8.
   PubMed Web of Science ®Google Scholar
• von Kalle C, Kiem H-P, Goehle S et al Increased gene trans-fer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood 1994;84:2890–7.
   PubMed Web of Science ®Google Scholar
• Burns JC, Friedmann T, Driever W et al. Vesicular stomati-tis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993;90:8033–7.
   PubMed Web of Science ®Google Scholar
• Hanenberg H, Hashino K, Konishi H et al. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum Gene Ther 1997;8: 2193–206.
   Google Scholar
• Murray L, Luens K, Tushinski R et al. Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, F1t3, and Kit ligands and RetroNectin culture. Hum Gene Ther 1999;10:1743.
   Google Scholar
• Hanenberg H, Xiao XL, Dilloo D et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996;2:876–82.
   PubMed Web of Science ®Google Scholar
• Moritz T, Patel VP, Williams DA. Bone marrow extracellu-lar matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. 7 Clin Invest 1994;93: 1451–7.
   Google Scholar
• Kiem HP, Morris J, Heyward S et al. Gene transfer into baboon hematopoietic repopulating cells using recombi-nant human fibronectin fragment Ch-296. Blood 1997;90 (Suppl):236a.
   Google Scholar
• Abonour R, Williams DA, Einhorn L et al. Efficient retro-virus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoi-etic stem cells. Nat Med 2000;6:652–8.
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G et al. Gene therapy of human severe combined immunodefi-ciency (SCID)-X1 disease Science 2000;288:669–72.
   Google Scholar
• Botnick LE, Hannon EC, Vigneulle R, Hellman S. Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res 1981;41:2338–41.
   Google Scholar
• Neben S, Hemman S, Montgomery M et al. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol 1993;21:156–62.
   PubMed Web of Science ®Google Scholar
• Maze R, Kapur R, Kelley MR et al. Reversal of 1,3-bis (2-chlorethyl 1)-i -nitrosourea-induced severe immuno-deficiency by transduction of murine long-lived hematopoi-etic progenitor cells using 06-methylguanine DNA methyltransferase complementary DNA..7 Immunol1 997;158: 1006-13.
   Google Scholar
• Hock RA, Miller AD. Retrovirus-mediated gene transfer and expression of drug resistance genes in human haematopoietic progenitor cells. Nature 1986;320:2 7 5–7 .
   Google Scholar
• Williams DA, Hsieh K, DeSilva A, Mulligan RC. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. 7 Exp Med 1987;166:210–18.
   PubMed Web of Science ®Google Scholar
• Corey CA, DeSilva A, Holland C, Williams DA. Serial transplantation of methotrexate-resistant bone marrow: Protection of murine recipients from drug toxicity by prog-eny of transduced stem cells. Blood 1990;75:337–43.
   PubMed Web of Science ®Google Scholar
• May C, Gunther R, McIvor RS. Protection of mice from lethal doses of methotrexate by transplantation with trans-genic marrow expressing drug-resistant dihydrofolate reductase activity. Blood 1995;86:2439–48.
   Google Scholar
• Zhao SC, Banerjee D, Mineishi S, Bertino JR. Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofo-late reductase cDNA. Hum Gene Ther 1997;8:903–9.
   Google Scholar
• Flasshove M, Banerjee D, Leonard JP et al. Retroviral trans-duction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA. Hum Gene Ther 1998;9:63–71.
   Google Scholar
• Flasshove M, Banerjee D, Mineishi S et al Ex vivo expansion and selection of human CD34+ peripheral blood progeni-tor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 1995;85:566–74.
   PubMed Web of Science ®Google Scholar
• Ercikan-Abali EA, Mineishi S, Tong Y et al. Active site-directed double mutants of dihydrofolate reductase. Cancer Res 1996;56:4142–5.
   Google Scholar
• Patel M, Sleep SEH, Lewis WS et al Comparison of the pro-tection of cells from antifolates by transduced dihydrofolate reductase mutants. Hum Gene Ther 1997;8:2069–77.
   Google Scholar
• Persons DA, Sorrentino BP. In vivo selection of genetically modified hematopoietic stem cells using a novel DHFR variant characterized by high level drug resistance. Blood 1999;94:365a.
   Google Scholar
• Beausejour CM, Le NL, Letourneau S et al Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate. Hum Gene Ther 1998;9: 2537–44.
   Google Scholar
• Galipeau J, Benaim E, Spencer HT et al A bicistronic retro-viral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs. Hum Gene Ther 1997;8:1773–83.
   PubMed Web of Science ®Google Scholar
• Sauerbrey A, McPherson JP, Zhao SC et al. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside. Hum Gene Ther 1999;10:2495–504.
   Google Scholar
• Zhao RC, McIvor RS, Griffin JD, Verfaillie CM. Gene therapy for chronic myelogenous leukemia (CML): a retro-viral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo. Blood 1997;90:4687–98.
   PubMed Web of Science ®Google Scholar
• Stromhaug A, Warren DJ, Slordal L. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action. Exp Hematol 1995;23: 439–43.
   Google Scholar
• Blau CA, Neff T, Papayannopoulou T The hematological effects of folate analogs: implications for using the dihydro-folate reductase gene for in vivo selection. Hum Gene Ther 1996;7:2069–78.
   Google Scholar
• Howell SB, Mansfield SJ, Taetle R. Thymidine and hypox-anthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicity. Cancer Res 1981;41:945–50.
   Google Scholar
• Li M-X, Banerjee D, Zhao S-C et al. Development of a retroviral construct containing a human mutated dihydro- folate reductase cDNA for hematopoietic stem cell trans-duction. Blood 1994;83:3403–8.
   PubMed Web of Science ®Google Scholar
• Allay JA, Spencer HT, Wilkinson SL et al. Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors. Blood 1997;90: 3546–54.
   PubMed Web of Science ®Google Scholar
• Allay JA, Persons DA, Galipeau J et al. In vivo selection of retrovirally transduced hematopoietic stem cells. Nat Med 1998;4:1136–43.
   PubMed Web of Science ®Google Scholar
• Mineishi S, Nakahara S, Takebe N et al. Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene. Gene Ther 1997;4:570–6.
   PubMed Web of Science ®Google Scholar
• Mineishi S, Nakahara S, Takebe N et al. Purine salvage rescue by xanthine-guanine phosphoribosyltransferase (XGPRT) potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene. Cancer Gene Ther 1998;5:144–9.
   Google Scholar
• Gottesman M, Pastan I. Biochemistry of multidrug resist-ance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385–427.
   PubMed Web of Science ®Google Scholar
• Mickisch G, Arsentijevich I, Schoenlein P et al. Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemo-therapy in mice. Blood 1992;79:1087–93.
   PubMed Web of Science ®Google Scholar
• Sorrentino BP, Brandt SJ, Bodine D et al Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 1992;257:99–103.
   PubMed Web of Science ®Google Scholar
• Ward M, Richardson C, Pioli P et al Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. Blood 1994;84:1408–14.
   PubMed Web of Science ®Google Scholar
• Bertolini F, DeMonte L, Corsini C et al. Retrovirus-mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cells. Br 7 Haematol 1994;88: 318–24.
   Google Scholar
• Schiedlmeier B, Kühlcke K, Eckert HG et al. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. Blood 2000;95:1237–48.
   PubMed Web of Science ®Google Scholar
• Eckert H-G, Stockschlader M, Just U et al High-dose mul-tidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vec-tors. Blood 1996;88:3407–15.
   PubMed Web of Science ®Google Scholar
• Hildinger M, Fehse B, Hegewisch-Becker S et al. Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. Hum Gene Ther 1998;9:33–42.
   Google Scholar
• Cowan KH, Moscow JA, Huang H et al. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complemen-tary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res 1999;5:1619–28.
   PubMed Web of Science ®Google Scholar
• Devereux S, Corney C, Macdonald C et al. Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphoma. Gene Ther 1998;5:403–8.
   Google Scholar
• Hanania EG, Giles RE, Kavanagh J et al. Results of MDR-1 vector modification trial indicate that granulocyte/ macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following inten-sive systemic therapy. Proc Natl Acad Sci USA 1996;93: 15346–51.
   PubMed Web of Science ®Google Scholar
• Hesdorffer C, Ayello J, Ward M et al. Phase I trial of retro-viral-mediated transfer of the human MDR-1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. Clin Onco/ 1998;16:165–72.
   Google Scholar
• Moscow JA, Huang H, Carter C et al. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 1999;94:52–61.
   PubMed Web of Science ®Google Scholar
• Rahman Z, Kavanagh J, Champlin R et al. Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer. Clin Cancer Res 1998;4:2717–21.
   Google Scholar
• Licht T, Aran JM, Goldenberg SK et al. Retroviral transfer of human MDR1 gene to hematopoietic cells: effects of drug selection and of transcript splicing on expression of encoded P-glycoprotein. Hum Gene Ther 1999;10:2173–85.
   Google Scholar
• Sorrentino BP, McDonagh KT, Woods D, Orlic D. Expression of retroviral vectors containing the human mul-tidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood 1995;86:491–501.
   PubMed Web of Science ®Google Scholar
• Bunting KD, Galipeau J, Topham D et al. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 1998;92:2269–79.
   PubMed Web of Science ®Google Scholar
• Chaudhary P, Roninson I. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hemato-poietic stem cells. Cell1991;66:85–94.
   PubMed Web of Science ®Google Scholar
• Cole SP, Bhardwaj G, Gerlach JH et al. Overexpression of a transporter gene in a multidrug-resistant human lung can-cer cell line. Science 1992;258:1650–4.
   PubMed Web of Science ®Google Scholar
• Barrand MA, Heppell-Parton AC, Wright KA et al. A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. 7 Natl Cancer Inst 1994;86: 110–17.
   Google Scholar
• Grant CE, Valdimarsson G, Hipfner DR et al. Over-expression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994;54:357–61.
   PubMed Web of Science ®Google Scholar
• D' Hondt V, Caruso M, Bank A. Retrovirus-mediated gene transfer of the multidrug resistance-associated protein (MRP) cDNA protects cells from chemotherapeutic agents. Hum Gene Ther 1997;8:1745–51.
   Google Scholar
• Zaman GJ, Flens MJ, van Leusden MR et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 1994;91:8822–6.
   Google Scholar
• Machiels JP, Govaerts AS, Guillaume T et al. Retrovirus-mediated gene transfer of the human multidrug resistance-associated protein into hematopoietic cells protects mice from chemotherapy-induced leukopenia. Hum Gene Ther 1999;10:801–11.
   PubMed Web of Science ®Google Scholar
• Barret JM, Hill BT. DNA repair mechanisms associated with cellular resistance to antitumor drugs: potential novel targets. Anticancer Drugs 1998;9:105–23.
   PubMedGoogle Scholar
• Chaney SG, Sancar A. DNA repair: enzymatic mechanisms and relevance to drug response. 7 Natl Cancer Inst 1996; 88:1346–60.
   PubMedGoogle Scholar
• Rajewsky ME Engelbergs J, Thomale J, Schweer T Relevance of DNA repair to carcinogenesis and cancer therapy. Recent Results Cancer Res 1998;154:127–46.
   Google Scholar
• Kawate H, Sakumi K, Tsuzuki T et al. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc Natl Acad Sci USA 1998;95:5116–20.
   Google Scholar
• Pegg AE, Dolan ME, Moschel RC. Structure, function, and inhibition of 06-alkylg-uanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol1995;51: 167–223.
   Google Scholar
• Ludlum DB. DNA alkylation by the halonitrosoureas: nature and modifications produced and their enzymatic repair or removal. Mutat Res 1990;233:117–26.
   PubMed Web of Science ®Google Scholar
• Robins P, Harris AL, Goldsmith I, Lindahl T Cross-linking of DNA induced by chloroethylnitrosourea is prevented by 06-methylg-uanine-DNA methyltransferase. Nucleic Acids Res 1983;11:7743–58.
   PubMedGoogle Scholar
• Brent TP, Remack JS. Formation of covalent complexes between human 06-alkylg-uanine-DNA alkyltransferase and BCNU-treated defined length synthetic oligodeoxynu-cleotides. Nucleic Acids Res 1988;16:6779–88.
   PubMed Web of Science ®Google Scholar
• Gerson S, Miller K, Berger N. 06-alkylguanine-DNA alky-transferase activity in human myeloid cells. 7 Clin Invest 1985;76: 2106–14.
   Google Scholar
• Gerson SL, Trey JE, Miller K, Berger NA. Comparison of 06-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis 1986;7:745–9.
   PubMed Web of Science ®Google Scholar
• Gerson SL, Phillips W, Kastan M et al. Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive 06-alkylguanine-DNA alkyltransferase and are sensitive to 06-benzylguanine plus BCNU. Blood 1996;88:1649–55.
   PubMedGoogle Scholar
• Weiss RB, Issell BF. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU). Cancer Treat Rev 1982;9:313–30.
   PubMed Web of Science ®Google Scholar
• Maze R, Moritz T, Williams DA. Increased survival and mul-tilineage hematopoietic protection from delayed and severe myelosuppressive effects of a nitrosourea with recombinant interleukin-11 (IL-11). Cancer Res 1994;54: 4947–51.
   Google Scholar
• Moritz T, Mackay W, Glassner BJ eta/. Retrovirus-mediated expression of a DNA repair protein in bone marrow pro-tects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res 1995;55:2608–14.
   Google Scholar
• Wang G, Weiss C, Sheng P, Bresnick E. Retrovirus-mediated transfer of the human 06-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alky-lating agents. Biochem Pharmacol 1996;51:1221–8.
   PubMed Web of Science ®Google Scholar
• Jelinek J, Fairbairn LJ, Dexter TM et al. Long-term pro-tection of hematopoiesis against the cytotoxic effects of multiple doses of nitrosourea by retrovirus-mediated expression of human 06-alkylg-uanine-DNA-alkyltrans-ferase. Blood 1996;87:1957–61.
   PubMedGoogle Scholar
• Allay JA, Dumenco LL, Koc ON et al. Retroviral transduc-tion and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 1995;85:3342–51.
   PubMed Web of Science ®Google Scholar
• Allay JA, Davis BM, Gerson SL. Human alkyltransferase-transduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice. Exp Hematol 1997;25:1069–76.
   Google Scholar
• Maze R, Carney JP, Kelley MR et al. Increasing DNA repairmethyltransferase levels via bone marrow stem cell trans-duction rescues mice from the toxic effects of 1,3-bis (2-chloroethyl)-1-nitrosourea, a chemotherapeutic alky-lating agent. Proc Natl Acad Sci USA 1996;93:206–10.
   PubMed Web of Science ®Google Scholar
• Mitchell RB, Moschel R, Dolan ME. Effect of 06-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis (2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. Cancer Res 1992;52: 1171–5.
   Google Scholar
• Dolan M, Moschel R, Pegg A. Depletion of mammalian 06-alkylg-uanine-DNA alkyltransferase activity by 06-benzylguanine provides a means to evaluate the role of the protein in protection against carcinogenic and therapeutic alkylation agents. Proc Natl Acad Sci USA 1990;87: 5368–72.
   Google Scholar
• Dolan ME, Mitchell RB, Mummert C et al. Effect of 06-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res 1991;51:3367–72.
   PubMed Web of Science ®Google Scholar
• Chinnasamy N, Rafferty JA, Hickson I et al. 06-benzylguanine potentiates the in vivo toxicity and clasto-genicity of temozolomide and BCNU in mouse bone marrow. Blood 1997;89:1566–73.
   PubMed Web of Science ®Google Scholar
• Spiro TP, Gerson SL, Liu L et al 06-benzylguanine: a clin-ical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair. Cancer Res 1999;59:2402–10.
   PubMed Web of Science ®Google Scholar
• Harris LC, Marathi UK, Edwards CC et al Retroviral trans-fer of a bacterial alkyltransferase gene into murine bone marrow protects against chloroethylnitrosourea cytotoxic-ity. Clin Cancer Res 1995;1:1359–68.
   PubMed Web of Science ®Google Scholar
• Koc ON, Reese JS, Szekely EM, Gerson SL. Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transfer. Cancer Gene Ther 1999;6:340–8.
   PubMed Web of Science ®Google Scholar
• Reese JS, Davis BM, Liu L, Gerson S L. Simultaneous pro- tection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitiza-tion of tumor cells using 06-benzylguanine and temozolomide. Clin Cancer Res 1999;5: 163–9.
   Google Scholar
• Davis BM, Reese JS, Koc ON et al. Selection for G156A 06-methylguanine DNA methyltransferase gene-trans-duced hematopoietic progenitors and protection from lethality in mice treated with 06-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. CancerRes 1997;57:5093–9.
   Google Scholar
• Davis BM, Koc ON, Gerson SL. Limiting numbers of G156A 06-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyelo-ablated mice after drug selection. Blood 2000;95: 3078–84.
   Google Scholar
• Ragg S, Xu-Welliver M, Bailey J et al. Direct reversal of DNA damage by mutant methyltransferase protein pro-tects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells. Cancer Res 2000;60:5187–95.
   PubMed Web of Science ®Google Scholar
• Davis BM, Roth JC, Liu L et al. Characterization of the P140K, PVP(138-140)MLK, and G156A 06-methylgua-nine-DNA methyltransferase mutants: implications for drug resistance gene therapy. Hum Gene Ther 1999;10: 2769–78.
   Google Scholar
• Koc ON, Reese JS, Davis BM et al. DeltaMGMT-trans-duced bone marrow infusion increases tolerance to 06-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts. Hum Gene Ther 1999;10:1021–30.
   Google Scholar
• Chen J, Derfler B, Maskati A, Samson L. Cloning a eukary-otic DNA glycosylase repair gene by the suppression of a DNA repair defect in Escherichia coli Proc Natl Acad Sci USA 1989;86:7961–5.
   Google Scholar
• Samson L, Derfler B, Boosalis M, Call K. Cloning and characterization of 3-methyladenine DNA glycosylase cDNA from human cells whose gene maps to chromosome 16. Proc Natl Acad Sci USA 1991;88:9127–31.
   Google Scholar
• Xiao W, Derfler B, Chen J, Samson L. Primary sequence and biological functions of a Saccharomyces cerevi siae 06-methylg-uanine/04-methylthymine DNA repair methyl-transferase gene. EMBO 7 1991;10:2179–86.
   PubMed Web of Science ®Google Scholar
• Habraken Y, Carter CA, Kirk MC, Ludlum DB. Release of 7-alkylguanines from N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea-modified DNA by 3-methyladenine DNA glycosylase II. Cancer Res 1991;51:499–503.
   PubMed Web of Science ®Google Scholar
• Kobune M, Parson S, Xu Y et al. Retrovirus-mediated expression of the base excision repair protein, APN1, pro-tects hematopoietic cells from bleomycin-induced toxicity in vitro and in vivo. Blood 1999;94:381a.
   Google Scholar
• Kastan MB, Schlaffer E, Russo JE et al. Direct demonstra-tion of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 1990;75:1947–50.
   PubMed Web of Science ®Google Scholar
• Magni M, Shammah S, Schiró R et al. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 1996;87:1097–103.
   PubMed Web of Science ®Google Scholar
• Bunting KD, Webb M, Giogianni F et al Coding region-specific destabilization of mRNA transcripts attenuates expression from retroviral vectors containing class 1 alde-hyde dehydrogenase cDNAs. Hum Gene Ther 1997;8: 1531–43.
   Google Scholar
• Black SM, Beggs JD, Hayes JD et al Expression of human glutathione S-transferases in Saccharomyces cerevisiae con-fers resistance to the anticancer drugs adriamycin and chlorambucil. 7 Biochem 1990268:309–15.
   Google Scholar
• Batist G, Tulpule A, Sinha BK et al. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. 7 Biol Chem 1986261:15549–9.
   Google Scholar
• Hirvonen A, Husgafvel-Pursiainen K, Antilla S, Vainio H. The GSTMI null genotype as a potential risk modifier for sqamous cell carcinoma of the lung. Carcinogenesis 1993;14:1479.
   PubMed Web of Science ®Google Scholar
• Doroshow JH, Metz MZ, Matsumoto L et al. Transduction of NIH 3T3 cells with a retrovirus carrying both human MDR1 and glutathione S-transferase produces broad-range multidrug resistance. Cancer Res 1995;55:4073–8.
   PubMed Web of Science ®Google Scholar
• Letourneau S, Palerme JS, Delisle JS et al Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts. Cancer Gene Ther 2000;7:757–65.
   Google Scholar
• Kuga T, Sakamaki S, Matsunaga T et al Fibronectin frag-ment-facilitated retroviral transfer of the glutathione-S-transferase ir gene into CD 34+ cells to protect them against alkylating agents. Hum Gene Ther 1997;8:1901–10.
   PubMedGoogle Scholar
• Steuart CD, Burke PJ. Cytidine deaminase and the devel-opment of resistance to arabinosyl cytosine. Nat New Biol 1971;233:109–10.
   PubMedGoogle Scholar
• Yusa K, Ohuhara T, Tsukahara S, Tsurua T Human immunodeficiency virus type 1 induces 1-13—arabinofura-nosylcytosine resistance in human H9 cell line. .7 Biol Chem 1992;267: 16848–50.
   Google Scholar
• Kuhn K, Bertling WM, Emmrich F. Cloning of a functional cDNA for human cytidine deaminase (CDD) and its use as a marker of monocyte/macrophage differentiation. Biochem Biophys Res Commun 1993;190:1–7.
   Google Scholar
• Laliberte J, Momparler RL. Human cytidine deaminase: purification of enzyme, cloning, and expression of its com-plementary DNA. Cancer Res 1994;54:5401–7.
   PubMed Web of Science ®Google Scholar
• Schröder JK, Kirch C, Flasshove M et al. Constitutive over-expression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro. Leukemia 1996;10:1919–24.
   Google Scholar
• Neff T, Blau CA. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine. Exp Hematol 1996;24:1340–6.
   PubMed Web of Science ®Google Scholar
• Momparler RL, Laliberte J, Eliopoulos N et al. Transfection of murine fibroblast cells with human cyti-dine deaminase cDNA confers resistance to cytosine arabinoside. Anticancer Drugs 1996;7:266–74.
   Google Scholar
• Momparler RL, Eliopoulos N, Bovenzi V et al. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibro-blast and hematopoietic cells. Cancer Gene Ther1996; 3:331–8.
   Google Scholar
• Flasshove M, Frings W, Schroeder J et al. Transfer of the cytidine deaminase cDNA into hematopoietic cells. Leukemia Res 1999;23:1047–53.
   PubMed Web of Science ®Google Scholar
• Eliopoulos N, Cournoyer D, Momparler RL. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxy-cytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells. Cancer Chemother Pharmacol1998;42: 373–8.
   Google Scholar
• Eliopoulos N, Bovenzi V, Le NLO et al Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice. Gene Therapy 1998;5:1545–51.
   Google Scholar
• Banerjee D, Tong Y, Liu-Chen X et al. Protection of bone marrow cells from toxicity of chemotherapeutic agents tar-geted toward thymidylate synthase by transfer of mutant forms of human thymidylate synthase cDNA. In: Bertino JR, editor. Marrow protection. Basel: Karger, ProgExp Tumor Res 1999; H;36: 107–14.
   Google Scholar
• Diasio RB. Dihydropyrimidine dehydrogenase and resist-ance to 5-fluorouracil. In: Bertino JR, editor. Marrow protec-tion. Basel: Karger, ProgExp Tumor Res 1999; H;36: 115–23.
   Google Scholar
• Suresh A, Tung F, Moreb J, Zucali JR. Role of manganese superoxide dismutase in radioprotection using gene trans-fer studies. Cancer Gene Then 1994;1:85–90.
   PubMed Web of Science ®Google Scholar
• Deisseroth AB, Zu Z, Claxton D et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994;83:3068–76.
   PubMed Web of Science ®Google Scholar